BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1768 related articles for article (PubMed ID: 18471545)

  • 21. Portal tract fibrogenesis in the liver.
    Ramadori G; Saile B
    Lab Invest; 2004 Feb; 84(2):153-9. PubMed ID: 14688800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
    Pinzani M
    J Hepatol; 2011 Aug; 55(2):459-65. PubMed ID: 21320559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic fibrogenesis.
    Guo J; Friedman SL
    Semin Liver Dis; 2007 Nov; 27(4):413-26. PubMed ID: 17979077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
    Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
    Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Origin and Fate of Liver Myofibroblasts.
    Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.
    Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K
    Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
    Tu T; Calabro SR; Lee A; Maczurek AE; Budzinska MA; Warner FJ; McLennan SV; Shackel NA
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1696-704. PubMed ID: 26239824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathobiology of liver fibrosis: a translational success story.
    Lee YA; Wallace MC; Friedman SL
    Gut; 2015 May; 64(5):830-41. PubMed ID: 25681399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications.
    Rockey DC
    Clin Liver Dis; 2000 May; 4(2):319-55. PubMed ID: 11232195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis.
    Ramm GA; Ruddell RG
    Semin Liver Dis; 2005 Nov; 25(4):433-49. PubMed ID: 16315137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    Zhang CY; Yuan WG; He P; Lei JH; Wang CX
    World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology of hepatic fibrosis].
    Vaĺková M
    Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis.
    Kisseleva T; Brenner DA
    J Hepatol; 2012 Apr; 56(4):965-72. PubMed ID: 22173163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving challenges in hepatic fibrosis.
    Friedman SL
    Nat Rev Gastroenterol Hepatol; 2010 Aug; 7(8):425-36. PubMed ID: 20585339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stellate cell activation in alcoholic fibrosis--an overview.
    Friedman SL
    Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.